Inflammation  >>  Lodonal (naltrexone low dose oral) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
2019-000852-32: A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study.

Not yet recruiting
2
122
Europe
Naltrexone hydrochloride, Tablet
ErasmusMC, ZonMw, ErasmusMC
Inflammatory Bowel Disease, Crohn's disease De ziekte van Crohn, Inflammatory Bowel Disease, Crohn's disease, Diseases [C] - Digestive System Diseases [C06]
 
 

Download Options